March 2013 FDA Recall Drug by L. Perrigo Co.
D-318-2013 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by L. Perrigo Co. on March 12, 2013 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-318-2013

Reason for Recall
Failed Impurities/Degradation Specifications: 3 month stability testing.
Initiated
03-12-2013
Reported
05-15-2013
Quantity
21,667 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
64729
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
L. Perrigo Co.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2013
Product Description About Product Description
Full technical description of the product.
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

Batch or Lot Expiration Information

Lot# 12K714 exp. 12/13, 12K715 exp. 12/13